Corrigendum to "Risk factors for interstitial lung disease in patients with non-small cell lung cancer with epidermal growth factor receptor-tyrosine kinase inhibitors: A systematic review and meta-analysis" [Respir Invest, Volume 62, Issue 3, May 2024, Pages 481-487].